Skip to main content

Advertisement

Log in

Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Thakral C, Thomas L, Gajra A, Hutchison RE, Ravizzini GC, Vajpayee N (2009) Plasmablastic lymphoma in an immunocompetent patient. J Clin Oncol 27(25):e78–81. doi:10.1200/JCO.2009.22.2208

    Article  PubMed  Google Scholar 

  2. Montes-Moreno S, Montalban C, Piris MA (2012) Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge. Leuk Lymphoma 53(2):185–194. doi:10.3109/10428194.2011.608447

    Article  CAS  PubMed  Google Scholar 

  3. Masgala A, Christopoulos C, Giannakou N, Boukis H, Papadaki T, Anevlavis E (2007) Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman. Ann Hematol 86(8):615–618. doi:10.1007/s00277-007-0280-z

    Article  PubMed  Google Scholar 

  4. Lin F, Zhang K, Quiery AT Jr, Prichard J, Schuerch C (2004) Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 128(5):581–584. doi:10.1043/1543-2165(2004)128<581:PLOTCL>2.0.CO;2

    PubMed  Google Scholar 

  5. Horna P, Hamill JR Jr, Sokol L, Glass LF (2013) Primary cutaneous plasmablastic lymphoma in an immunocompetent patient. J Am Acad Dermatol 69(5):e274–276. doi:10.1016/j.jaad.2013.06.050

    Article  PubMed  Google Scholar 

  6. Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, Portlock C, Noy A (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673–1679. doi:10.1093/annonc/mdh399

    Article  CAS  PubMed  Google Scholar 

  7. Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A, Ojanguren J, Romagosa V, Jaffe ES, Campo E (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28(6):736–747

    Article  PubMed  Google Scholar 

  8. Yan M, Dong Z, Zhao F, Chauncey T, Deauna-Limayo D, Wang-Rodriguez J, Liu D, Wang HY, Pilz R (2014) CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab. Eur J Haematol. doi:10.1111/ejh.12286

    PubMed  Google Scholar 

  9. Blade J, Fernandez de Larrea C, Rosinol L, Cibeira MT, Jimenez R, Powles R (2011) Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol 29(28):3805–3812. doi:10.1200/JCO.2011.34.9290

    Article  PubMed  Google Scholar 

  10. Sekiguchi Y, Asahina T, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Komatsu N, Noguchi M (2013) A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literature. J Clin Exp Hematop: JCEH 53(1):21–28

    Article  PubMed  Google Scholar 

Download references

Funding source

None.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Holger W. Auner.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Figure 1

CT-PET scan of a representative PET-positive lesion in the cervical spine that is not osteolytic as shown by the CT component of the scan. (JPEG 68 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johnston, A.C., Naresh, K., Barwick, T. et al. Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma. Ann Hematol 94, 691–692 (2015). https://doi.org/10.1007/s00277-014-2226-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2226-6

Keywords

Navigation